The Cancer

Don't Miss

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...

Vital Information

Facts

Latest Articles

Consuming Ideas for When Most cancers Therapy Makes Meals Difficult

Greek yogurt, egg salad, avocado and mac and cheese are easy-to-swallow, high-calorie meals that may assist sufferers preserve energy throughout most cancers therapy.Kenisha...

CAR T-Cell Remedy Results in Remission in Retired Air Drive Pilot With Lymphoma

Dr. Andre Henri Goy of John Theurer Most cancers Middle shared the story of a affected person with lymphoma who achieved remission after...

When Most cancers Advocacy Turns into a Lifeline

Morgan Newman shares how self-advocacy helped her overcome boundaries to care and discover the help she wanted after remedy.As a most cancers survivor,...

High 5 Updates Sufferers Ought to Know

June introduced main breast most cancers updates, and CURE is sharing the most recent therapy combos, biomarker-driven care and affected person well-being.As June...

A Journey of Adaptation and Hope

Ronald Chin acquired a analysis of a number of myeloma in January 2017 and has been in remission since October 2023. Compensate for...

Hot Topics